AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32924207 — intervention group
Group type: EXPERIMENTAL
Intervention: cBAI (computer-delivered brief alcohol intervention)
Number of subjects: 138
Study 32924207 — intervention group
Group type: COMPARATOR
Intervention: Standard care (brief education and advice)
Number of subjects: 138
Study 35201931 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar intrathecal fentanyl (FENT)
Number of subjects: 20
Study 35201931 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 20
Study 35201931 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 20
Study 35201931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 36462609 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 59
Study 36462609 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 59
Study 33626500 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise programs that include deadlifts
Number of subjects: 3
Study 33626500 — intervention group
Group type: COMPARATOR
Intervention: Low load motor control exercises
Number of subjects: 3
Study 32740235 — intervention group
Group type: EXPERIMENTAL
Intervention: mFOLFIRINOX
Number of subjects: 103
Study 32740235 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine/nab‐paclitaxel
Number of subjects: 103
Study 32740235 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative therapy
Number of subjects: 103
Study 32740235 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative complications
Number of subjects: 103
Study 33199491 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomically directed therapy
Number of subjects: 177
Study 33199491 — intervention group
Group type: COMPARATOR
Intervention: Physician's choice
Number of subjects: 177
Study 32363656 — intervention group
Group type: EXPERIMENTAL
Intervention: General cognitive training (GCT)
Number of subjects: 4184
Study 32363656 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4184
Study 34220720 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey Protein (15 g)
Number of subjects: 24
Study 34220720 — intervention group
Group type: COMPARATOR
Intervention: Placebo (water, 100 ml)
Number of subjects: 24
Study 35980261 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine hydrobromide (4-6 µg/kg)
Number of subjects: 40
Study 35980261 — intervention group
Group type: COMPARATOR
Intervention: Glycopyrronium bromide (4 µg/kg)
Number of subjects: 40
Study 33410336 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Cognitive Behavioral Therapy for Insomnia (bCBTi) - four weekly sessions
Number of subjects: 19
Study 32401718 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet rich plasma intradermal injections
Number of subjects: 30
Study 35003725 — intervention group
Group type: EXPERIMENTAL
Intervention: One-time combination cefazolin 2 g and metronidazole 500 mg preoperatively
Number of subjects: 250
Study 35003725 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinzaparin 4500 units SC daily for at least 7 days after discharge
Number of subjects: 250
Study 35003725 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 250
Study 33157325 — intervention group
Group type: EXPERIMENTAL
Intervention: Open flap debridement (OFD) + adjunctive photodynamic therapy (PDT)
Number of subjects: 0
Study 33157325 — intervention group
Group type: COMPARATOR
Intervention: Open flap debridement (OFD)
Number of subjects: 0
Study 35618650 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedated esophagogastroduodenoscopy followed by unsedated colonoscopy (Group A)
Number of subjects: 3200
Study 35618650 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedated esophagogastroduodenoscopy followed by sedated colonoscopy (Group B)
Number of subjects: 3200
Study 35618650 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedated esophagogastroduodenoscopy followed by sedated insertion colonoscopy (Group C)
Number of subjects: 3200
Study 34140010 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG scar present
Number of subjects: 1320
Study 34140010 — intervention group
Group type: COMPARATOR
Intervention: BCG scar absent
Number of subjects: 1320
Study 34140010 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall birthweight
Number of subjects: 1320
Study 34140010 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal factors
Number of subjects: 1320
Study 32030616 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 75
Study 32030616 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 75
Study 35352627 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser treatment
Number of subjects: 0
Study 35352627 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone treatment
Number of subjects: 0
Study 35352627 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 0
Study 35470799 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-month DAPT after PF-DCS
Number of subjects: 2020
Study 35470799 — intervention group
Group type: COMPARATOR
Intervention: 6-12-month DAPT after BP-DES
Number of subjects: 2020
Study 32350016 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored diabetes education and behavioural weight management programme (DEW)
Number of subjects: 576
Study 32350016 — intervention group
Group type: COMPARATOR
Intervention: Diabetes education programme (DE)
Number of subjects: 576
Study 35158461 — intervention group
Group type: EXPERIMENTAL
Intervention: Inebilizumab
Number of subjects: 17
Study 33862589 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexyn2a vaccine (10 µg)
Number of subjects: 67
Study 33862589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 33758921 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified dairy fat meals (25g SFAs, 20g MUFAs for breakfast; 15g SFAs, 12g MUFAs for lunch)
Number of subjects: 52
Study 33758921 — intervention group
Group type: COMPARATOR
Intervention: Control dairy fat meals (32g SFAs, 12g MUFAs for breakfast; 19g SFAs, 7g MUFAs for lunch)
Number of subjects: 52
Study 35257698 — intervention group
Group type: EXPERIMENTAL
Intervention: iCanQuit
Number of subjects: 550
Study 35257698 — intervention group
Group type: COMPARATOR
Intervention: QuitGuide
Number of subjects: 550
Study 33208642 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer-based portable navigation system (navigation group)
Number of subjects: 100
Study 33208642 — intervention group
Group type: COMPARATOR
Intervention: Conventional intramedullary femoral guide and extramedullary tibial guide (conventional group)
Number of subjects: 100
Study 35175316 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine maintenance therapy (1000 mg/m2 orally twice daily on days 1‐14 every 3 weeks) plus best supportive care (BSC)
Number of subjects: 104
Study 35175316 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (BSC) alone
Number of subjects: 104
Study 35175316 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine maintenance therapy
Number of subjects: 104
Study 34536718 — intervention group
Group type: EXPERIMENTAL
Intervention: PGDT group
Number of subjects: 482
Study 34536718 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 482
Study 34591500 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Short‐Term Dynamic Psychotherapy (ISTDP)
Number of subjects: 27
Study 32283187 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-week lifestyle behavior intervention promoting stress management, healthy eating, and physical activity
Number of subjects: 0
Study 32283187 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 0
Study 35467744 — intervention group
Group type: EXPERIMENTAL
Intervention: NHFOV
Number of subjects: 1440
Study 35467744 — intervention group
Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 1440
Study 35467744 — intervention group
Group type: COMPARATOR
Intervention: NIPPV
Number of subjects: 1440
Study 32985999 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice-Button Reporting (VBR)
Number of subjects: 57
Study 32985999 — intervention group
Group type: COMPARATOR
Intervention: Voice-Only Reporting (VOR)
Number of subjects: 57
Study 32985999 — intervention group
Group type: EXPERIMENTAL
Intervention: System Usability Scale (SUS)
Number of subjects: 57
Study 35763213 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral 600 IU vitamin D supplementation
Number of subjects: 40
Study 35763213 — intervention group
Group type: COMPARATOR
Intervention: No supplementation (Control)
Number of subjects: 40
Study 33632921 — intervention group
Group type: EXPERIMENTAL
Intervention: Community outreach methods and community liaison support
Number of subjects: 166
Study 35759611 — intervention group
Group type: EXPERIMENTAL
Intervention: Online discussion with no fact-check available
Number of subjects: 320
Study 35759611 — intervention group
Group type: EXPERIMENTAL
Intervention: Online discussion with fact-check from traditional media
Number of subjects: 320
Study 35759611 — intervention group
Group type: EXPERIMENTAL
Intervention: Online discussion with fact-check from a fact-check organization
Number of subjects: 320
Study 35759611 — intervention group
Group type: COMPARATOR
Intervention: Control group with no online discussion
Number of subjects: 320
Study 33156757 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirical TB treatment
Number of subjects: 850
Study 33156757 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 850
Study 35941979 — intervention group
Group type: EXPERIMENTAL
Intervention: Core balance training
Number of subjects: 0
Study 35941979 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 33685241 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline period included
Number of subjects: 0
Study 33685241 — intervention group
Group type: EXPERIMENTAL
Intervention: No baseline period
Number of subjects: 0
Study 32098946 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Hz rTMS
Number of subjects: 56
Study 32098946 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 56
Study 34182842 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized cognitive remediation therapy (CCRT)
Number of subjects: 20
Study 34182842 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study 33905129 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 SQ-Bet
Number of subjects: 929
Study 33905129 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 929
Study 32393159 — intervention group
Group type: EXPERIMENTAL
Intervention: Neighborhood-level residential mobility (percentage of residents living in a different house in the past year and percentage of non-owner-occupied housing)
Number of subjects: 418
Study 32393159 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual-level factors (male gender, older age, unemployment, lower education level)
Number of subjects: 418
Study 35797241 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (GLP-1 analogue) for 6 months
Number of subjects: 30
Study 35797241 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (GLP-1 analogue)
Number of subjects: 30
Study 35797241 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 30
Study 32277781 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically elevated LDL cholesterol
Number of subjects: 1286
Study 32277781 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically elevated total cholesterol
Number of subjects: 1286
Study 32277781 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cholesterol PRS
Number of subjects: 1286
Study 32277781 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL cholesterol PRS
Number of subjects: 1286
Study 32277781 — intervention group
Group type: COMPARATOR
Intervention: HDL cholesterol PRS
Number of subjects: 1286
Study 32277781 — intervention group
Group type: COMPARATOR
Intervention: Triglycerides PRS
Number of subjects: 1286
Study 35281554 — intervention group
Group type: EXPERIMENTAL
Intervention: 104 mg subcutaneous injection of Depo‐subQ
Number of subjects: 101
Study 35281554 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg subcutaneous injection of Depo‐Provera
Number of subjects: 101
Study 35281554 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of 150 mg Depo‐Provera every 6 months
Number of subjects: 101
Study 35281554 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of Depo‐subQ at 3-month intervals
Number of subjects: 101
Study 35240330 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Dietary Advice (TDA)
Number of subjects: 99
Study 35240330 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP Diet (LFD)
Number of subjects: 99
Study 35240330 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-Free Diet (GFD)
Number of subjects: 99
Study 35240330 — intervention group
Group type: EXPERIMENTAL
Intervention: All diets (TDA, LFD, GFD)
Number of subjects: 99
Study 36053934 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention-based cognitive behavioral treatment (nine weekly sessions)
Number of subjects: 51
Study 36053934 — intervention group
Group type: COMPARATOR
Intervention: Active-control (not specified)
Number of subjects: 51
Study 33630880 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week diet break with increased energy intake (carbohydrate) to predicted weight maintenance requirements
Number of subjects: 26
Study 33197559 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg daily
Number of subjects: 84
Study 33197559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 32406573 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobeglitazone (0.5 mg)
Number of subjects: 247
Study 32406573 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin (100 mg)
Number of subjects: 247
Study 33390282 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 1364
Study 33390282 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use in the IAD arm
Number of subjects: 1364
Study 34823497 — intervention group
Group type: EXPERIMENTAL
Intervention: PDA10 (Epoetin-alpha)
Number of subjects: 0
Study 34823497 — intervention group
Group type: COMPARATOR
Intervention: Eprex®
Number of subjects: 0
Study 34823497 — intervention group
Group type: EXPERIMENTAL
Intervention: PDA10
Number of subjects: 0
Study 34823497 — intervention group
Group type: EXPERIMENTAL
Intervention: PDA10 and Eprex®
Number of subjects: 0
Study 33167893 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric ear acupuncture (EEA)
Number of subjects: 56
Study 33167893 — intervention group
Group type: COMPARATOR
Intervention: Control group (spinal anesthesia alone)
Number of subjects: 56
Study 35690151 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitored Anesthesia Care (MAC)
Number of subjects: 204
Study 35690151 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 204
Study 33667525 — intervention group
Group type: EXPERIMENTAL
Intervention: TAS-102 (trifluorothymidine and tipiracil)
Number of subjects: 0
Study 33667525 — intervention group
Group type: EXPERIMENTAL
Intervention: TAS-102
Number of subjects: 0
Study 32093742 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC) monotherapy at a dosage of 0.05-0.1 mg/kg/day for 6 months
Number of subjects: 0
Study 32093742 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide (CTX) combined with glucocorticoid
Number of subjects: 0
Study 35256183 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified complete dentures
Number of subjects: 40
Study 35256183 — intervention group
Group type: COMPARATOR
Intervention: Conventional complete dentures
Number of subjects: 40
Study 35902197 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrectomy combined with lens capsule flap transplantation
Number of subjects: 54
Study 35902197 — intervention group
Group type: COMPARATOR
Intervention: ILM tamponade
Number of subjects: 54
Study 33765241 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient Multimodal Occupational Rehabilitation (I‐MORE)
Number of subjects: 166
Study 33765241 — intervention group
Group type: COMPARATOR
Intervention: Outpatient Acceptance and Commitment Therapy (O‐ACT)
Number of subjects: 166
Study 32173882 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-plane MFU-V treatment (4.5 mm)
Number of subjects: 30
Study 32173882 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-plane MFU-V treatment (4.5 and 3.0 mm)
Number of subjects: 30
Study 32173882 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 30
Study 35086362 — intervention group
Group type: EXPERIMENTAL
Intervention: IVH expansion
Number of subjects: 500
Study 34166799 — intervention group
Group type: EXPERIMENTAL
Intervention: History of depression
Number of subjects: 894
Study 35477884 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) and anorganic bovine bone mineral (ABBM) complex with collagen membrane
Number of subjects: 16
Study 35477884 — intervention group
Group type: COMPARATOR
Intervention: Anorganic bovine bone mineral (ABBM) with collagen membrane
Number of subjects: 16
Study 34694869 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin nebulization
Number of subjects: 63
Study 34694869 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 63
Study 35783511 — intervention group
Group type: EXPERIMENTAL
Intervention: honey and fenugreek
Number of subjects: 75
Study 35783511 — intervention group
Group type: COMPARATOR
Intervention: fenugreek
Number of subjects: 75
Study 32345286 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided counseling using the health belief model and the theory of planned behavior; 4 counseling sessions before 16 weeks of gestation
Number of subjects: 694
Study 32345286 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided counseling using the health belief model and the theory of planned behavior
Number of subjects: 694
Study 32345286 — intervention group
Group type: COMPARATOR
Intervention: Routine nutrition education provided by the health care system (Control)
Number of subjects: 694
Study 33780315 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight and fast injection
Number of subjects: 180
Study 33780315 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight and slow injection
Number of subjects: 180
Study 33780315 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunneled and fast injection
Number of subjects: 180
Study 33780315 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunneled and slow injection
Number of subjects: 180
Study 32211800 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamin fortification
Number of subjects: 68
Study 32211800 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk nutrient concentrations
Number of subjects: 68
Study 32211800 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 68
Study 33835354 — intervention group
Group type: EXPERIMENTAL
Intervention: Surviving and Thriving in the Real World (STRW) intervention
Number of subjects: 12
Study 33835354 — intervention group
Group type: EXPERIMENTAL
Intervention: Entire sample analyses with 10 participants
Number of subjects: 12
Study 33835354 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 12
Study 34707012 — intervention group
Group type: EXPERIMENTAL
Intervention: BOLD-MRI-based radiomics
Number of subjects: 141
Study 35906051 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training for 6 weeks
Number of subjects: 26
Study 35906051 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric training for 6 weeks
Number of subjects: 26
Study 35906051 — intervention group
Group type: COMPARATOR
Intervention: Asymptomatic controls
Number of subjects: 26
Study 33987636 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch ART (n=4166)
Number of subjects: 7316
Study 33987636 — intervention group
Group type: COMPARATOR
Intervention: Stable Baseline Regimen (SBR) (n=3150)
Number of subjects: 7316
Study 33987636 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch from efavirenz (EFV) to rilpivirine (RPV) or elvitegravir/cobicistat
Number of subjects: 7316
Study 33987636 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF)
Number of subjects: 7316
Study 33987636 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch from abacavir to TAF
Number of subjects: 7316
Study 33934514 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with midazolam (DEX group)
Number of subjects: 433
Study 32330093 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded standing exposure and exercise (intervention)
Number of subjects: 0
Study 32330093 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit-stand desk use (intervention)
Number of subjects: 0
Study 32330093 — intervention group
Group type: COMPARATOR
Intervention: No instruction (control)
Number of subjects: 0
Study 35012439 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual cognitive stimulation (iCS) - 47 weekly sessions
Number of subjects: 59
Study 35012439 — intervention group
Group type: COMPARATOR
Intervention: Control group - maintained baseline treatments
Number of subjects: 59
Study 35616194 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-finger technique (TFT) with real-time visual feedback (RVF)
Number of subjects: 59
Study 35616194 — intervention group
Group type: EXPERIMENTAL
Intervention: One-hand technique (OHT) without RVF
Number of subjects: 59
Study 35616194 — intervention group
Group type: EXPERIMENTAL
Intervention: One-hand technique (OHT) with RVF
Number of subjects: 59
Study 33371066 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention based on quantitative evaluation
Number of subjects: 50
Study 35788765 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture-specific, motivated, action-based intervention in addition to usual care
Number of subjects: 150
Study 35788765 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study 32964773 — intervention group
Group type: EXPERIMENTAL
Intervention: Teleaudiology follow-up consultation
Number of subjects: 56
Study 32964773 — intervention group
Group type: COMPARATOR
Intervention: Standard face-to-face follow-up consultation
Number of subjects: 56